News Archive

October 2020

GCAR, Amgen, & Eisai Announce First Patient Enrolled in International COVID-19 Trial
October 28, 2020

AMGEN and Eisai to Participate in the Immune Modulation Domain of REMAP-COVID, an Adaptive Clinical Trial to Test Interventions for Patients Hospitalized with COVID-19

AMGEN’s Apremilast and Eisai’s Eritoran to be Evaluated Across Multiple International Trial Sites Within the Remap Network

On…read more...